Objective To investigate the effects of Kanglaite injection combined with chemotherapy on quality of life and myelosuppression in patients with non-small cell lung cancer(NSCLC).Methods The clinical data of 60 patients with NSCLC who received treatment at Zhejiang Jinhua Guangfu Tumor Hospital from August 2018 to February 2022 were retrospectively analyzed.These patients were divided into an experimental group and a control group,with 30 patients in each group according to the treatment methods used.The patients in the experimental group received the Kanglaite injection in combination with chemotherapy using gemcitabine and cisplatin,whereas the patients in the control group were treated solely with chemotherapy with gemcitabine and cisplatin.The quality of life was evaluated using the Karnofsky Performance Status score.Before and after treatment,a comparison was made between the two groups in terms of Karnofsky Performance Status score,the incidence of adverse reactions(such as myelosuppression),and clinical efficacy.Results After treatment,the disease control rate and objective response rate in the experimental group were 86.67％(26/30)and 60.00％(18/30),respectively,which were significantly higher than 60.00％(18/30)and 30.00％(9/30)in the control group(x2=4.18,4.31,both P＜0.05).Prior to treatment,the Karnofsky Performance Status scores in the experimental and control groups were(70.68±3.75)points and(70.29±5.11)points(t=0.34,P=0.790),respectively.After treatment,the Karnofsky Performance Status scores in the experimental group were significantly higher than those in the control group[(67.02±5.87)points vs.(62.37±3.59)points,t=-5.29,P＜0.05].The incidence of adverse reactions in the experimental group was significantly higher than that in the control group[40.00％(12/30)vs.36.67％(11/30),x2=0.07,P=0.790).Additionally,the incidence of myelosuppression in the experimental group was significantly lower than that in the control group[56.67％(17/30)vs.86.67％(26/30),x2=6.90,P=0.030].Conclusion Compared with chemotherapy alone,Kanglaite injection combined with chemotherapy can effectively relieve the clinical symptoms of patients with advanced non-small cell lung cancer,leading to improved prognosis.
Carcinoma,non-small-cell lungAntineoplastic combined chemotherapy protocolsQuality of lifeDrug-related side effects and adverse reactionsPrognosisKanglaite injection
NETL
NSTL
万方数据
